Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan; Notification of Proposed Production Activity; Pfizer, Inc. (Lipid Active Pharmaceutical Ingredients), Kalamazoo, Michigan, 15911 [2022-05810]
Download as PDF
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 54 / Monday, March 21, 2022 / Notices
country’s growing infrastructure needs.
The ACS is the only available survey
that can provide these levels of data in
a timely, consistent, and standardized
manner.
To evaluate the proposed changes, the
2022 Content Test will include a control
and two experimental treatments. The
Control Treatment will include the
current ACS (production) version of the
questions. New topics will also be
included in this treatment. The Test
Treatment will include the test question
version for all topics except household
roster. Because changes to withinhousehold coverage can impact results
of person-level questions, the household
roster question(s) will be the current
production version in order to avoid
confounding. Changes to the roster
question(s) will be tested in a separate
treatment, called the Roster Treatment.
Additionally, health insurance coverage,
labor force, and income will include a
second set of experimental questions to
be tested in the Roster Treatment.
Each topic will be evaluated using a
variety of metrics, including item
missing data rates, response
distributions, comparisons to
benchmarks and administrative data,
response reliability, and other topicspecific metrics. Comparisons will be
made between the Control Treatment
and the experimental treatments. In
some cases, the two experimental
treatments will also be compared.
Results of the test will inform decisions
about changing content on the ACS.
Affected Public: Individuals or
households.
Frequency: One-time test.
Respondent’s Obligation: Mandatory.
Legal Authority: Title 13 U.S.C.
Sections 141, 193, and 221.
This information collection request
may be viewed at www.reginfo.gov.
Follow the instructions to view the
Department of Commerce collections
currently under review by OMB.
Written comments and
recommendations for the proposed
information collection should be
submitted within 30 days of the
publication of this notice on the
following website www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under 30-day
Review—Open for Public Comments’’ or
by using the search function and
VerDate Sep<11>2014
21:01 Mar 18, 2022
Jkt 256001
entering either the title of the collection
or the OMB Control Number 0607–0936.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2022–05937 Filed 3–18–22; 8:45 am]
BILLING CODE 3510–07–P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–8–2022]
Foreign-Trade Zone (FTZ) 43—Battle
Creek, Michigan; Notification of
Proposed Production Activity; Pfizer,
Inc. (Lipid Active Pharmaceutical
Ingredients), Kalamazoo, Michigan
Pfizer, Inc. (Pfizer) submitted a
notification of proposed production
activity to the FTZ Board (the Board) for
its facility in Kalamazoo, Michigan
within Subzone 43E. The notification
conforming to the requirements of the
Board’s regulations (15 CFR 400.22) was
received on March 11, 2022.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status materials/
components and specific finished
products described in the submitted
notification (summarized below) and
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz. The proposed finished products and
materials/components would be added
to the production authority that the
Board previously approved for the
operation, as reflected on the Board’s
website.
The proposed finished products
include active pharmaceutical
ingredients for Pfizer’s COVID–19
vaccine—Lipid ALC-0159 K Finished
and Lipid ALC-0315 Crude (duty rate is
3.7% or 6.5%).
The proposed foreign-status materials
and components include: Methoxy
Polyethylene Glycol (MPEG) Acid;
Enzyme CDX-616; Registered Starter
Chemical PF-07321332; 2,2,6,6Tetramethylpiperidine-1-Oxyl; 1Propanephosphonic Acid Cyclic
Andydrid; 4-Amino-1-Butanol;
Tetamine NS Succinate Salt; and, 2Hexyldecanoic Acid (duty rate ranges
from duty free to 6.5%). The request
indicates that certain materials/
components are subject to duties under
Section 301 of the Trade Act of 1974
(Section 301), depending on the country
PO 00000
Frm 00004
Fmt 4703
Sfmt 4703
15911
of origin. The applicable Section 301
decisions require subject merchandise
to be admitted to FTZs in privileged
foreign status (19 CFR 146.41).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is May 2,
2022.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact Diane
Finver at Diane.Finver@trade.gov.
Dated: March 15, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022–05810 Filed 3–18–22; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
Bureau of Industry and Security
Emerging Technology Technical
Advisory Committee; Notice of
Partially Closed Meeting
The Emerging Technology Technical
Advisory Committee (ETTAC) will meet
on April 8, 2022, at 11 a.m., Eastern
Daylight Time. The meeting will be
available via teleconference. The
Committee advises the Office of the
Assistant Secretary for Export
Administration on the identification of
emerging and foundational technologies
with potential dual-use applications as
early as possible in their developmental
stages both within the United States and
abroad.
Agenda
Open Session
1. Welcome and Introductions.
2. Introduction by the Bureau of
Industry and Security Leadership.
3. Presentation: Bringing the
Chipmakers Home—Attracting
Manufactures and the Talent to Sustain
Them. Questions and Answers.
4. Public Comments/Announcements.
Closed Session
5. Discussion of matters determined to
be exempt from the provisions relating
to public meetings found in 5 U.S.C.
App. 10(a)(1) and 10(a)(3).
The open session will be accessible
via teleconference. To join the
conference, submit inquiries to Ms.
Yvette Springer at Yvette.Springer@
bis.doc.gov no later than April 1, 2022.
To the extent time permits, members
of the public may present oral
statements to the Committee. The public
E:\FR\FM\21MRN1.SGM
21MRN1
Agencies
[Federal Register Volume 87, Number 54 (Monday, March 21, 2022)]
[Notices]
[Page 15911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05810]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-8-2022]
Foreign-Trade Zone (FTZ) 43--Battle Creek, Michigan; Notification
of Proposed Production Activity; Pfizer, Inc. (Lipid Active
Pharmaceutical Ingredients), Kalamazoo, Michigan
Pfizer, Inc. (Pfizer) submitted a notification of proposed
production activity to the FTZ Board (the Board) for its facility in
Kalamazoo, Michigan within Subzone 43E. The notification conforming to
the requirements of the Board's regulations (15 CFR 400.22) was
received on March 11, 2022.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status materials/components and
specific finished products described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via www.trade.gov/ftz. The proposed finished
products and materials/components would be added to the production
authority that the Board previously approved for the operation, as
reflected on the Board's website.
The proposed finished products include active pharmaceutical
ingredients for Pfizer's COVID-19 vaccine--Lipid ALC-0159 K Finished
and Lipid ALC-0315 Crude (duty rate is 3.7% or 6.5%).
The proposed foreign-status materials and components include:
Methoxy Polyethylene Glycol (MPEG) Acid; Enzyme CDX-616; Registered
Starter Chemical PF-07321332; 2,2,6,6-Tetramethylpiperidine-1-Oxyl; 1-
Propanephosphonic Acid Cyclic Andydrid; 4-Amino-1-Butanol; Tetamine NS
Succinate Salt; and, 2-Hexyldecanoic Acid (duty rate ranges from duty
free to 6.5%). The request indicates that certain materials/components
are subject to duties under Section 301 of the Trade Act of 1974
(Section 301), depending on the country of origin. The applicable
Section 301 decisions require subject merchandise to be admitted to
FTZs in privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is May 2, 2022.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
[email protected].
Dated: March 15, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-05810 Filed 3-18-22; 8:45 am]
BILLING CODE 3510-DS-P